NCT03339752

A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin

A Single-center, Open-label, One-sequence, Two-treatment Study to Investigate the Effect of ACT-541468 at Steady State on the Pharmacokinetics of Rosuvastatin in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Idorsia Pharmaceuticals Ltd. · Industry
• Sex: Male
• Age: 18 Years – 64 Years
• Healthy volunteers: Accepted

Summary

A study in healthy male subjects to investigate whether administration of ACT-541468 can affect the fate in the body (amount and time of presence in the blood) of rosuvastatin

Conditions

• Healthy Subjects

Interventions

Type	Name	Description
DRUG	Rosuvastatin	10 mg tablet
DRUG	ACT-541468	25 mg hard capsule

Timeline

• Start date: 2017-10-30
• Primary completion: 2017-12-02
• Completion: 2017-12-02
• First posted: 2017-11-13
• Last updated: 2017-12-11

Locations

1 site across 1 country: Czechia